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Abstract
In recent years, the development of various cyclodextrin (CD)-based  
nanosponges (NSs) has gained great importance in the controlled and-or targeted 
release of drugs due to their versatility and simple preparation. In this chapter, an 
introduction of different administration routes is explained. Further, different ways 
to obtain CD-NSs and their classification are shown with a brief explanation of the 
characterization of the inclusion complexes. Finally, illustrative examples in diverse 
processes or diseases will be reviewed and explained to demonstrate the potential  
of CD-NSs. Therefore, this division will serve to compile information on CD-NSs  
in recent years and to illustrate to readers how to generate and apply different  
derivatives of interest.
Keywords: Cyclodextrin nanosponges, drug delivery, synthesis, nanocarrier, release
1. Introduction
Society demands better treatments for each disease and therefore the industry 
tries to obtain them. Novel drugs with better bioactivity are researched to achieve 
the best result in our bodies. However, several novel drugs present problems related 
to their chemical properties that prevent them from being used as a pharma or 
nutraceutical product. The molecule can be unstable in water solution, and/or easily 
oxidized, and presents poor bioavailability. Different strategies might improve the 
current therapy. One possibility is to find a good formulation, which stabilizes the 
drug or carries it to the desired tissue. Moreover, the adverse effect due to the dosage 
can also be reduced. For this reason, a great number of carriers are been proposed to 
challenge the previous problems.
One of them is called cyclodextrin (CD), truncated cone-shaped oligosac-
charides made up of α-(1→4) linked glucopyranoside units with six, seven 
and eight glucose units, α, β and γ-CD, respectively [1, 2]. A derivative called 
2-Hydroxypropyl-βCD (HPβ-CD) is used as an orphan drug for Niemann Pick 
disease type C [3, 4]. Complexes formed of molecules and cyclodextrins (CDs) 
are called “inclusion complexes”. Generally, CDs encapsulate poorly water-soluble 
compounds and hydrophobic moieties of amphiphilic molecules. Nevertheless, the 
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solubility of these complexes not only depends on the CD used but also on different 
factors such as pH or guess molecule [5–8]. The capacity of CDs to increase solubil-
ity and protect several molecules has increased their use in the pharmaceutical and 
food industries [1, 9, 10].
However, the improvement achieved by adding CDs is sometimes insufficient. 
Then, researchers developed a novel material based on these excipients baptized 
as Cyclodextrin-based Nanosponge (CD-NS), innovative cross-linked polymer 
structures with a three-dimensional network, and with a crystalline and amorphous 
structure, spherical and possessing good swelling properties [11]. Recent reviews 
[12–14] point to their wide potential and minimal toxicity [15, 16]. Some applica-
tions of these polymers include i) increasing the apparent solubility of poorly 
soluble drugs, ii) modulating drug release and activity, iii) protecting drugs against 
several agents, iv) enhancing bioactivities, v) absorbing contaminants ability, vi) 
delivering the drug, etc.
Cross-linking CDs brings significant benefits to CD-NSs compared with the 
respective native CDs. In general, CD-NSs can form complexes with a series of dif-
ferent molecules due to their structure. They achieve a hindered diffusion of loaded 
guest molecules, thus promoting slower release kinetics [17, 18]. Another important 
property of CD-NSs is that they can be easily recovered from aqueous media and 
recycled. Although they are insoluble, soluble hyperbranched NS can also be 
synthesized [19]. Finally, one of their principal disadvantages has been recently 
solved, they have been tested as a good carrier not only for small molecules but also 
for higher ones like proteins [20, 21].
This chapter tends to be a first step for the researcher who starts with CD-NSs: 
i) an introduction of the routes of administration, including advantages and 
disadvantages is explained, ii) an explanation about the various types of CD-NSs, 
including its synthesis and classification is written, iii) the different ways to charac-
terize the inclusion complexes are reported and iv) examples of smart delivery are 
displayed as an encourage study to demonstrate their potential.
2. Routes of administration, advantages, and disadvantages
The choice of the route of administration is crucial as it dramatically affects 
drug bioavailability and thus requires specific delivery strategies. Parenteral 
routes include intravenous, intramuscular, and subcutaneous routes, whereas the 
enteral routes are the oral, sublingual, and rectal routes [22]. Others are inhalation, 
intranasal, etc. [23]. In this section, each route will be described briefly and special 
attention will be paid to the oral route, which is the most desired but, at the same 
time, the most challenging.
When administered via intravenous injection (IV), the drug reaches the sys-
temic circulation directly bypassing absorption and carrying out its effect rapidly. 
This route is ideal for unstable or scarcely absorbed drugs (e.g. blood products), 
and irritating drug formulations, the administration of which via subcutaneous and 
intramuscular routes will be painful. It is also intended for patients who are not able 
to take the formulations orally, due to mental disorders, nausea, or vomiting.
Intramuscular injection (IM) can involve various muscles, including the gluteal 
muscle to which up to 5 ml of the formulation can be administered. Via this route, 
aqueous or oil-based solutions, suspensions, and emulsions are accepted. Aqueous 
solutions are generally absorbed in 10–30 minutes, whereas drugs insoluble at 
interstitial pH or suspended in oil-based solutions present a long time of absorp-
tion. Vascularisation of the muscle, the volume, and the osmolarity of the injected 
formulations also affect the absorption time. A depot preparation of the drug can 
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be given via this route with a sustained release of the drug into the bloodstream. IM 
injection is selected when the drug has a low oral bioavailability or when the patient 
is not compliant. Vaccines are also administered via this route.
Subcutaneous injections can be given in the forearm or abdomen. Up to 2 ml of 
the formulation can be administered. Together with aqueous solutions and suspen-
sions, adrenalin can be added to induce vasoconstriction and therefore increase 
the residence time of drugs (e.g. local anesthetics) or hyaluronidase to make the 
extracellular matrix more fluid, thus improving the absorption rate.
The absorption rate is extremely variable as it is influenced by the blood flow. 
Subcutaneous injections are also used for depot formulations. It is easy to admin-
ister and requires minimal skills, thus allowing self-administration. Insulin and 
heparin are given via this route.
Among all, oral delivery has been recognized as the most attractive route, as it is 
cheap, simple, accepted by patients, requires fewer sterility restrictions, and offers 
more possibilities in the design of the formulation (including sustained and con-
trolled delivery) [24]. It is used for drugs with topical action in the gut and systemic 
effects when they reach the bloodstream. However, it is not suitable for emergencies 
in which an immediate effect is fundamental.
Over the past few years, many efforts have been made to develop oral delivery 
systems able to overcome the obstacles in the gastrointestinal tract (GI) in which the 
mechanism of absorption is complex with multiple levels of barriers [24].
There is a long list of variables that influence the GI absorption of drugs, which 
are grouped in technical challenges, physicochemical properties of the drug, and 
environmental factors [25].
The technical challenges concern the pharmaceutical form, i.e. liquid or solid. 
In solid forms, the rate and extent of disintegration, and dissolution of the formula-
tion are important to a drug, and to carry out its effect, needs to be in a solution for 
developing the absorption.
Most drugs are absorbed in the small intestine, characterized by a large surface 
area of absorption and having a crucial influence on bioavailability.
The walls of the GI tract are characterized by the presence of mucus, which 
has been a target for drug delivery systems (DDS) capable of mucopenetration or 
mucoadhesion [24]. Mucopenetration consists in regulating the hydrophobicity/
hydrophilicity of the carrier’s matrix or combining mucolytic enzymes to promote 
drug penetration. On the contrary, mucoadhesive carriers, which have attracted sig-
nificant attention [26–28], can adhere to mucus, thus increasing the residence time. 
CD NSs have proven to possess this property, making them particularly promising 
for oral delivery [20].
Last but not least, the first-pass effect should be borne in mind when dealing 
with the oral route as it is certainly a limiting factor. It refers to the metabolism 
(mainly in the liver) of the drug before it reaches the systemic circulation, which 
may lead to a drop in bioavailability [29]. For this reason, several drugs are adminis-
tered via other enteral routes (e.g. rectal and sublingual).
The sublingual route offers the benefit of bypassing the first-pass effect due to 
the passive diffusion through the highly permeable mucosa underneath the tongue. 
It is simple with a low risk of infection and the effect is rapid. Nitroglycerin is 
administered via this route.
The rectal route exploits the highly vascularized rectal mucosa for drug absorp-
tion. The first-pass effect is partially avoided. It is indicated for patients with 
gastrointestinal motility problems, nausea, vomiting, and children.
Inhalation is used to obtain a rapid effect as the drug crosses the large surface 
area of the respiratory tract epithelium and reaches the systemic circulation. 
It avoids the first-pass metabolism. The particle size and morphology of the 
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formulation inhaled are crucial. It is mainly used for the treatment of respiratory 
diseases. The intranasal route enables the drug to be absorbed via passive diffusion 
across the highly-vascularised respiratory epithelium directly into the systemic 
circulation. Nasal decongestants and anti-allergic drugs are administered via this 
route (Table 1).
3. Synthesis and classification of CD-NSs
The choice of appropriate synthetic conditions, allowed to obtain both water-
soluble and water-insoluble polymer products, known also as CD-NSs or insoluble, 
and branched or soluble polymer [30–32]. The latter case allowed to overcome the 
limits of pristine CDs in terms of solubility in water and specific organic solvent, 
while the resulting formation of a three-dimensional cross-linked network was 
related to the presence of interstitial spaces among the monomers [33]. In this 
regard, the nature of the cross-linker and its amount in respect to the CD, ratio 
which defines the so-called cross-linking density, are presented to have a great 
impact on the properties and structure of the final material [34]. Also, being said 
interstices wider and more hydrophilic in respect to the cavities of CDs, a wider 







• not Emergency therapy
• not for GI-sensitive drugs (unless they 
are encapsulated
• first pass effect
• risk of interaction with food and drugs
Sublingual • rapid effect
• suitable for emergency therapy
• uncertain dosage
Rectal • for pediatric use
• for patients with impaired GI 
function
• risk of irritation
• unpredictable absorption
Inhalation • rapid absorption
• suitable for general anesthesia and 
emergency therapy
• risk of irritation
• specific equipment is needed
Intravenous • suitable for emergency therapy
• adjustable
• accurate dosage
• complications due to rapid onset
• allergic reactions
Intramuscular • rapid absorption
• systemic administration of hydro-
philic drugs




• care must be taken to avoid veins and 
arteries
• risk of infections and abscesses
Subcutaneous • rapid absorption
• administration of sustained-release 
formulations
• administration of very small volumes
Table 1. 
Advantages and disadvantages of the main routes of administration.
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3.1 General synthesis protocol
The most common method announced for the synthesis of CD based polymers, 
is characterized by employing a suitable solvent which could be either organic 
solvent or, in specific cases water, for the dissolution of the CDs. Afterwards, under 
continuous stirring, the chosen linking agent is added to the solution. Nevertheless, 
when required, the introduction of a catalyst occurs before the linking agent, and 
in specific cases, an increase in temperature is necessary to start the cross-linking 
reactions. The use of an ultrasound bath instead of stirring was also considered 
[35]. Eventually, either a sol–gel process or a precipitation polymerization can be 
observed, leading to the formation of a monolithic block or a precipitate, respec-
tively. Also, in those cases in which the cross-linker is in the liquid form, and able to 
solubilize the CD, a melt polymerization can be performed [36, 37].
Once the synthesis is completed, the solvent, the catalyst, eventual unreacted 
monomers, and by-products are removed from the synthesized product by purifica-
tion with water or other volatile solvents. In the end, a dry solid powder is collected 
[37–39]. Another well-known approach to synthesize CD-NSs is achieved through 
simple dehydration reactions. In this case, the CDs and the cross-linker, which is 
usually an acid bearing two or more carboxylic groups, are solubilized in water. 
After the addition of a suitable catalyst, the solution is heated to remove the water 
introduced as solvent as well as the water released as a by-product of the cross-
linking condensation reaction. Moreover, the use of vacuum together with the 
temperature allows to shift the equilibrium of the reaction toward the products [40, 
41]. Besides, less used synthetic routes report the use of interfacial or radical polym-
erization. In the first case, two immiscible phases such as a water solution of CD and 
a chlorinated solvent solution containing the chosen cross-linker, are mixed and 
stirred vigorously. The cross-linking occurs rapidly at the interface of the immiscible 
phases, and a precipitate is obtained [39]. While in the second case, a multistep 
procedure involving also preliminary derivatization of CD was displayed [42].
3.2 General classification
In general, based on the technological evolution of these materials, CD-NSs can 
be classified into four generations, considering their chemical composition and 
properties [19]. The first generation comprises all those NSs synthesized by a simple 
one-step reaction of CDs with a cross-linker. This generation was further divided into 
sub-categories according to the chemical nature of the linking molecules adopted for 
the synthesis. In this frame, carbonate, ester, ether, and urethane types are the most 
reported. These specific types of NSs will be described in more detail in the following 
paragraphs. Subsequently, the introduction of specific functions such as charge or 
luminescence to the final polymer structure defined the second generation of NSs. 
These materials displayed more complex polymer architectures achieved either via 
pre- or post-synthesis functionalization. In the first case, the introduced functions 
were limited to the surface of the polymer, whereas in the second case a more homo-
geneous distribution was observed. Referring to the division into generations, the 3rd 
generation deals with stimuli-responsive NSs, able to modulate their behavior (for 
example increasing/decreasing a drug release) according to the external environment.
3.2.1 CD-based polyurethane NSs
Urethane, or carbamate, CD-NSs are synthesized by reacting CDs (or a different 
dextrin) with a suitable diisocyanate as, for example, hexamethylene diisocyanate 
(HDI), toluene–2,4-diisocyanate (TDI). The reaction scheme is reported below 
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(Figure 1, inset a). The resulting NSs are usually characterized by a rigid structure and 
a negligible swelling in water (in comparison with other CD-NSs), and organic solvent 
and high resistance to chemical degradation. Carbamate CD-NSs, were originally 
developed by Li and Ma for the treatment of wastewaters, as an alternative for acti-
vated carbon. They demonstrated with NSs remarkable performances in the removal 
of organic molecules such as p-nitrophenol reducing concentration of waste from 
10−7–10−9 M to ppt level. The surface area was usually lower than activated carbon, 
(1–2 m2/g, two orders of magnitude) but it is supposed that organic molecules can be 
adsorbed, diffuse through the surface, and be absorbed inside the bulk of NSs [43].
The good affinity of organic molecules showed for pollutants [44], is also dem-
onstrated by the application of urethane NSs in the complexation with biologically 
relevant compounds, such as bilirubin or amino acids. In 2006, Tang et al. evaluated 
the difference in absorption of aromatic amino acids and branched-chain amino 
acids: the absorption of branched-chain amino acids was negligible whereas NSs 
absorbed 24% of the aromatic amino acids.
In previous works the same polymer was tested for the absorption of bilirubin, 
reducing the initial concentration of bilirubin (40 mg/l) up to 92.6% after the addi-
tion of the NS [45].
3.2.2 CD-based polycarbonate NSs
Polycarbonate CD-NSs are usually synthesized using active difunctional carbonyl 
compounds such as 1,1′-carbonyldiimidazole, triphosgene, and diphenylcarbonate 
(Figure 1, inset b). Since the resulting CD NSs present carbonate bonds between 
CD monomers, these NSs present short cross-linking bridges and, consequentially, 
a reduced swelling ability (if compared to CD- based polyesters NSs, for example) 
and good stability to acidic solutions. The affinity to organic molecules and the 
surface area are comparable to carbamate NS [46]. The ability of β-CD carbonate NS 
to remove from wastewater chlorinated persistent organic pollutants (also known as 
POP) was investigated by Trotta and Cavalli in 2009 [47]: the absorption efficiency 
was higher than the average of activated carbon. For the specific case of hexachloro-
benzene the NS was capable of removing around 99.5% of the pollutant.
Figure 1. 
Schematic synthesis of a) CD-based polyurethane NSs and b) CD-based polycarbonate NSs.
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An interesting method to evaluate the degree of cross-linking of carbonate β-CD 
NSs, employing infrared and Raman spectroscopy, was described by Castiglione et 
al. [48]. Data from spectroscopic analysis and chemical computation demonstrated 
a correlation between the intensity of carbonyl absorption peak and the degree of 
cross-linking: the degree of cross-linking increased with the amount of cross-linker, 
in total agreement with the stoichiometry. Dealing with sugar-based predominantly 
amorphous materials, the reported method represents a valid and advantageous 
alternative to x-ray. The crosslinking density or the amount of crosslinker, strongly 
influences the stiffness and elastic properties of the NSs. Rossi et al. demonstrated 
in their study that the mechanical features of the NSs can be easily tuned by chang-
ing the molar ratio CD/cross-linker, on the other hand, the CD used for the synthe-
sis does not affect the mechanical properties of the final NS [34, 49].
3.2.3 CD-based polyester NSs
Ester CD-based NSs are synthesized using dianhydrides or di/polycarboxylic 
acids, such as pyromellitic dianhydride (PMDA), ethylenediamine- tetraacetic 
dianhydride (EDTA dianhydride), butanetetracarboxylic dianhydride, citric acid 
[46, 50].
Dissimilarly from polycarbonate and polyurethane NSs, polyester NSs are gener-
ally able to absorb remarkable amounts of water (up to 25 times/g dry sample), 
and form stable hydrogels. Similarly as seen before with mechanical properties, the 
swelling capability of the CD-NSs is generally dependent on the degree of cross-
linking. The swelling capability is usually inversely proportional to the density of 
cross-linking: the lower the degree of cross-linking, the higher the water uptake. 
The structure of the material dramatically influences chemical stability. Ester NSs 
are subjected to hydrolysis in aqueous media more easily than polycarbonate and 
polyurethane NSs. The structure is remarkably interesting because of the presence 
of free carboxyl groups in their chemical structure, moieties that can be exploited 
for the absorption of cations, using the material as an ionic exchange resin.
There are in literature many examples of the formation of complexes with a 
metal cation. The metal ions complexation ability of pyromellitic NSs is studied by 
Berto et al. in for different metal cations, such as Al3+, Mn2+, Co2+, Ni2+, Cu2+, Zn2+, 
Cd2+ and Pd2+.
In most cases, pyromellitic NSs were found to be capable of absorbing more than 
70% of the tested cation [51].
A similar test of removing heavy metals from wastewaters, crosslinking also 
CDs with citric acid, is performed by Rubin Pedrazzo et al. in 2019 [52]. At a metal 
concentration of 500 ppm, the pyromellitic NSs (substituted before absorption 
with Na+) exhibited a higher retention capacity than the citrate NSs. At lower metal 
concentrations (≤ 50 ppm) both the citrate and the pyromellitic NSs showed high 
retention capacities (up to 94% of the total amount of metal). While in the pres-
ence of interfering sea water salts, the citrate NSs were able to selectively adsorb a 
significantly higher amount of heavy metals than the pyromellitic NSs.
For ester NSs, similar studies of the correlation of cross-linking degree with 
properties are performed. Surprisingly, the highest cross-linking degree was 
observed in the sample prepared using the molar ratio 1: 6, CD: PMDA [53].
Higher contents of cross-linker, molar ratios like 1:8 and 1:10, led to a 
decrease of the degree of cross-linking; this is possibly related to the steric 
hindrance generated by the pyromellitic units linked to CDs. Interestingly, by 
working under limited dilution conditions during the reaction and with an even 
lower CD/cross-linker ratio (e.g., 1:2 molar ratio), it is possible to obtain a hyper-
branched water-soluble polymer [54]. As already described for carbonate NSs, 
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Raman and Brillouin scattering experiments permitted Rossi et al. to evaluate a 
relationship between the mechanical characteristics of the polyester pyromellitic 
β-CD NS and the molar ratios CD/cross-linker: as seen before, stiffness and 
elasticity of the polymeric structure can be tuned by varying the amount of 
cross-linker [49].
4. Inclusion complex preparation and analysis
4.1 Preparation of inclusion complexes
Once the CD-NS is ready, the inclusion complex can be obtained by several 
procedures [55] as its summarized in Figure 2. Firstly, it is performed the classical 
mixing of drug and CD-NS in a solvent, commonly water for 24 h to form the com-
plexes. In this procedure, we should consider the insoluble or soluble nature of our 
complexes. Depending on this, the desire fraction is purified. Using kneading, the 
drug and the CD-NS are mixed in a mortar with an appropriate quantity of water 
or another solvent to form the complexes. At this point, other additional techniques 
are used to form the powder: The solvent can be removed using lyophilization, co-
evaporation, or spray-drying procedures.
4.2 Analysis of inclusion complexes
Different techniques can be employed to characterize not only inclusion com-
plexes but also CD-NS. For information purposes, we will name some of them and 
briefly explain their possibilities [56, 57]:
4.2.1 Ultraviolet/visible spectroscopy
UV–vis is a simple, easy, and fast method for studying the host-guest com-
plexation when its formation changes any particularity of the spectrum of a guest 
molecule or to check the solubilization efficacy [14, 16, 58, 59].
Figure 2. 
Different methods to prepare inclusion complexes.
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4.2.2 Fourier-transform infra-red (FTIR)
This technique is usually used in solid complexes, generally in the range of 
400–4000 cm−1, although it depends on the studied drug [58, 60]. Changes in the 
characteristics bands of the guest molecule or shifts in the wavenumber can indicate 
the formation of the complex. In addition, the same principle can be used to follow 
the CD-NS synthesis.
4.2.3 Nuclear magnetic resonance (NMR) spectroscopy
NMR is one of the most useful procedures to obtain complete analytical infor-
mation of the CD-NS and the complex formed. An alteration in the chemical shift 
of the protons occurs when the drug enters the CD-NS providing specific informa-
tion about the orientation of the guest molecule inside the cavity.
4.2.4 Thermogravimetric analysis (TGA)
TGA determines the changes of weight to temperature increases. The com-
parison of the weight loss profile of pure components, physical mixture, and the 
complex shows differences correlatives to the complex formation. A stage on TGA 
around 300°C is found in CD-NS due to CD decomposition [59].
4.2.5 Differential scanning calorimetry (DSC)
It can provide detailed information about their physical and energetic proper-
ties. The comparison of the thermal curves of single components, their physical 
mixture, and the presumed inclusion compound ought to provide insight into 
modifications and interactions due to the formation of the inclusion complex. The 
change that occurs in the fusion point of the guest molecule is usually hiding by 
the complex formation, while it remains in the physical mixture. This, and several 
modifications in the shape and temperature peak of the CD dehydration and/or 
with the disappearance of the drug melting peak among others, are proves of the 
complexation.
5. Applications in smart drug delivery
5.1 Improving solubility and controlled release of drugs
5.1.1 CD-based polyurethane NSs
Another study showed the capability of CD polyurethane to reduce the levels 
of natural product contaminants, particularly, Ochratoxin A (OTA) from spiked 
solutions between 1 and 10 μgL-1 [61]. Following the attracted considerable interest 
that these polymers have shown in their use for water purification systems [62] and 
drug delivery [63], there were further done several chemical modifications on the 
CD NSs. Even though the modified CD NSs were used to enhance the properties 
and usefulness of CD NSs, their characterization at the molecular level remained 
a challenge. Therefore, a study described the structural characterization at the 
molecular level of both, native CD nanosponge polyurethanes and bionanosponge 
polyurethane cyclodextrin nanocomposite (pMWCNT-CD/Ag-TiO2) showing a 
great antibacterial and antifungal activity. The greatest antimicrobial activities 
were in the case of the developed polyurethane nanocomposite (pMWCNT-CD/
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Ag-TiO2). Consequently, it was concluded that this developed synthesis can be 
considered an active antimicrobial compound [64]. Another potential application 
of CD polyurethane polymer is as immobilization supports in enzyme catalysis. The 
lipase was immobilized into the aforementioned polymers via physisorption. It is 
observed an improvement in the stability and catalytic activity of lipase, knowing 
that the enzymes are generally unstable, insoluble in organic solvents, and sensitive. 
Accordingly, this study presented the chance to prepare immobilized biocatalysts 
with tunable catalytic activities attributed to the alteration of reaction conditions 
[65]. Further research was focused on the novel polyurethanes containing simulta-
neously β-cyclodextrin (β-CD), β-glycerophosphate groups, and hexamethylene-
diisocyanate (HDI). This polymer developed was used to complex the delivering 
therapeutic agents such as antibiotic ciprofloxacin. It was observed an improvement 
of the drug release in the case of the drug-polymers complexation than that of the 
free drug [63].
5.1.2 CD-based polycarbonate NSs
CD-based polycarbonate NSs synthesized using carbonyldiimidazole (CDI) 
showed antimicrobial activity against various microorganisms such as E. coli, S. 
aureus, P. aeruginosa, S. typhi, C. albicans, and Clostridia, when compared with 
Ciprofloxacin that was used as a standard drug. The formulations were prepared 
by polymer condensation, and interfacial phenomenon, and were effective for 
6 months at a condition of 40°C and 75% of relative humidity [66]. This type of 
CD NSs was further used to deliver and increase the activity of several anticancer 
drugs such as paclitaxel [67], bortezomib [68], flutamide [69], tamoxifen [70], etc. 
Following their high potential to entrap a variety of molecules, the β-CD/CDI NSs 
were also used to deliver and improve the solubility and dissolution of paliperidone, 
an antipsychotic drug for the treatment of schizophrenia [71]. Further, rilpivirine is 
used for the treatment of HIV infection but has low aqueous solubility. Therefore, 
the β-CD/CDI NSs presented a strategy to improve this drawback and also the 
bioavailability and dissolution rate [72]. The antioxidant activity of kynurenic acid, 
an endogenous substance, was improved by loading it in β-CD/CDI NSs. The higher 
antioxidant activity was observed because of the increment in solubilization of 
kynurenic acid [60]. CD-based polycarbonate NSs synthesized using diphenyl car-
bonate (DPC) were used to overcome the poor solubility and stability of Babchi oil 
that is known for possessing numerous activities such as antifungal, antibacterial, 
antiviral, antitumor, antioxidant, etc. [73]. Further, the bioactive properties of the 
piperine, an alkaloid with anti-microbial, anti-inflammatory, anti-cancer proper-
ties, etc., were protected by the β-CD/DPC NSs [74]. This type of NSs exhibited 
complexing ability toward nifedipine, as an oral calcium channel blocking agent 
that is used to treat angina pectoris and hypertension. It was observed an improve-
ment in the oral solubility of nifedipine after its incorporation into NSs [75].
5.1.3 CD-based polyester NSs
CD-based Ester NSs synthesized with pyromellitic dianhydride (PMDA) are 
well known for delivering, enhancing solubility, and preventing the degradation 
of various drugs such as Curcumin [76], Insulin [20], Resveratrol [77], Erlotinib 
hydrochloride [78], among others. Ethylenediaminetetraacetic dianhydride 
(EDTA) is another cross-linker to synthesize ester CD NSs. Based on HRMAS 
probe-heads in a high-resolution NMR spectrometer on the transport properties 
of Ibuprofen sodium salt (IP), it was found that these NSs can be utilized for the 
rational design of smart systems for drug delivery and controlled release [79]. The 
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various applications of CD-based polyester NSs ranging from the environment to 
pharmacy, chemistry, agriculture, gene delivery, cosmetics, biocatalysis, brought 
to a detailed study on their cross-linking density. Being a very challenging task, it 
presented the effect of cross-linking density on β-CD NSs physicochemical proper-
ties. Flory-Rehner theory and rheology enabled the authors to understand the corre-
lation between the structural features of NSs and their physicochemical properties, 
which is a key requirement for future applications [34].
5.2 Last generations of NSs for selected target drug delivery
Stimuli-responsive NSs represent the third generation, polymers that have been 
designed to modulate their behavior according to the surrounding environment. In 
this case, changes in the chemical structure of the material were reported to be trig-
gered by pH, temperature gradients, or oxidative/reducing conditions. This feature 
was exploited for studying the targeted release of drugs, changes in color, and 
permeability. The use of glutathione (GSH) bioresponsive CD-NS was proposed as 
the system to deliver anticancer drugs or bioactive compounds [114–117]. This is 
because GSH is 100 to 1000 times higher inside cells than that in the extracellular 
fluids and circulation. Indeed, in cancer cells, this concentration is almost higher 
being a good system for target drug delivery [118]. Different drugs such as doxoru-
bicin [115] or bioactive compounds such as resveratrol [116] were tested showing 
a well-targeted drug delivery, and therefore is considered a promising therapy. In 
addition, the linkage of cholesterol was proposed as a good procedure for increase 
the targeted drug delivery of doxorubicin-loaded CD-NS [119].
Lastly, molecularly imprinted cyclodextrin-based polymers (Figure 3) define 
the fourth generation of NSs. Molecular imprinting represents a specific approach 
of inducing molecular recognition features to a three-dimensional polymer. 
This property can be achieved as a result of the presence of a template molecule 
introduced during synthesis. The template molecule after being removed from 
the polymer matrix leaves size-complementary vacancies, enabling the network 
to display high selectivity and affinity toward the chosen template. Eventually, 
Figure 3. 










βCD/HDI Long-term sustained release of 
antibiotics.
[80]




Curcumin βCD/DMC Increased anti-cancer drug solubility, 
and prolonged release.
[82]
Norfloxacin βCD/DPC Enhanced anti-bacterial drug 
permeability.
[83]
Tamoxifen βCD/CDI Increased anti-cancer drug solubility, 
and bioavailability.
[84]
Resveratrol βCD/CDI Increased the permeation, stability, 
and cytotoxicity against cancer
[85]
Camptothecin βCD/DPC Increased anti-cancer drug stability, 
and prolonged release.
[86]
Acyclovir βCD/CDI Enhanced anti-viral drug loading, 
and prolonged release.
[87]
Telmisartan βCD/DPC Enhanced anti-hypertensive drug 
solubility, improved bioavailability, 
and prolonged release.
[88]
Babchi Oil βCD/DPC Enhanced anti-bacterial essential oil 




Enhanced anti-viral drug solubility, 
and bioavailability.
[90, 91]
Paclitaxel βCD/CDI Enhanced anti-cancer drug solubility, 
and pharmacological effect.
[92]
Sulfamethoxazole βCD/CDI Enhanced anti-bacterial drug 
solubility.
[93]
Quercetin βCD/DPC Enhanced anti-oxidative drug 
dissolution, and prolonged release.
[94]
Melatonin βCD/CDI Controlled drug release through skin. [95]
Kynurenic acid βCD/CDI Enhanced anti-oxidant potential of 
kynurenic acid.
[96]
D-Limonene βCD/DPC Enhanced anti-bacterial potential 
of the drug.
[97]
Azelaic acid βCD/DPC Enhanced drug solubility, and its 
depigmenting action on the skin 
via antioxidant, and antityrosinase 
effect.
[98]
Chrysin βCD/DPC Enhanced drug solubility, in-vitro 
antioxidant, and antitumoral 
activity.
[99]
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molecularly imprinted CD-NSs are studied as suitable material to develop biosen-
sors, drug delivery systems, catalysts, or synthetic antibody mimics [120–122]. 
A good example of this application is the L-Dopa as a novel possibility to treat 
Parkinson’s Disease. The molecularly imprinted CD-NSs showed a slower and more 
prolonged release profile than the non-imprinted NSs, indicating the good capacity 
to better complex L-Dopa than non-imprinted NS. The use of CDs in controlled and 




Ferulic acid βCD/DPC Enhanced drug solubility, and 
bioavailability for the local therapy 
of vessels wall.
[101]
Flutamide βCD/CDI Enhanced anti-cancer drug 
dissolution rate.
[102]
Griseofulvin βCD/DPC Enhanced antifungal oral drug 




Insulin βCD/PMDA Enhanced anti-diabetic drug 
stability, and prolonged release.
[104]
Imiquimod βCD/PMDA Enhanced drug aqueous solubility, 
and skin permeation capability.
[105]
Acetyl salicylic acid βCD/PMDA Enhanced anti-inflammatory drug 
stability, and prolonged release.
[106]
Doxorubicin βCD/PMDA Improved anti-cancer effectiveness. [107]




DB103 - [2-(3, 
4-dimethoxyphenyl)-3-
phenyl-4H-pyrido]
βCD/DPC Enhanced drug solubility, and 

















Enhanced antioxidant potential, 
and it is useful in targeting chemo-
resistant tumors.
[111]
Strigolactones GSH/pH-NS Enhanced anticancer activity. [112]
Erlotinib hydrochloride 
(ETB)
GSH-NS Exhibited excellent drug 
uptake, extended drug release, 
in-vivo antitumor efficacy, and 
biodistribution.
[113]
βCD, Beta Cyclodextrin; ϒCD, Gama Cyclodextrin; HDI, Hexamethylene diisocyanate; CDI, Carbonyldiimidazole; 
DMC, Dimethyl Carbonate; DPC, Diphenyl carbonate; PMDA, Pyromellitic Dianhydride.
Table 2. 
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6. Conclusions
CD-NSs are demonstrated to be safe, cheap, and biocompatible polymers. 
Consequently, several authors are focused on this field recently achieving novel 
applications. This chapter summarized the general information that will guide 
the advanced research to investigate the CD-NSs. Information about the routes of 
administration, synthesis protocols, recommendations, classifications, and applica-
tions of the novel synthesized materials, with special attention to targeted drug 
delivery, are mostly collected. It is shown the ability of CD-NSs to entrap drugs 
and to control their release from the matrix which can be modulated by different 
physicochemical agents.
As a remark, CD-NS is a good promise to improve the current problems in drug 
formulations and open novel strategies for drug delivery that identify the light in 
the future.
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